Stanford University
Showing 1,931-1,940 of 34,898 Results
-
Nasim Bararpour
Basic Life Research Scientist, Genetics
BioNasim Bararpour is a postdoctoral fellow in the Department of Genetics and Personalized Medicine at Stanford School of Medicine, where she works at the intersection of data science, and multi-omics integration. She completed her Ph.D. in Life Science from the University of Lausanne, developing deep expertise in mass spectrometry-based metabolomics and lipidomics as well as integrative omics. She joined Stanford in 2020.
At Stanford, Dr. Bararpour has led and contributed to some of the most comprehensive multi-omics studies to date, including the human Personalized Omics Profiling (hPOP) project, the integrative Personal Omics Profiling (iPOP) study, and the Human Tumor Atlas Network (HTAN). Her first-authored paper in Cell (2026), which integrated thirteen molecular layers across individuals of diverse ancestries, identified ethnicity-specific drug target patterns and molecular pathways with direct implications for cardiometabolic disease, making a scientific case for population-aware precision medicine. She is the author of over 20 peer-reviewed publications, including papers in Nature Metabolism, and Nature Biomedical Engineering. -
Grant Barber
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Grant Barber is a Clinical Assistant Professor at Stanford University. His clinical passion is in the care of patients suffering from inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. After completing his medical training at Harvard Medical School, he completed his training in gastroenterology as well as a Master's degree in clinical research at Stanford. He completed additional training in advanced IBD management at Stanford before joining faculty. His research is focused on male reproductive health in IBD, quality improvement in the provision of IBD care, and economic studies to identify strategies that provide excellent outcomes while being sustainable within the healthcare system. He is an expert in tailoring evidence-based therapies to need of individual people with IBD.
